CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021
Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and CliniciansSOUTH SAN FRANCISCO, Calif., April 20, 2021...
Day: April 20, 2021
Intra-Cellular Therapies Announces Board of Director Nominations in Advance of 2021 Annual Meeting
Board of Directors Nominates Sir Michael Rawlins GBE M.D., FRCP, FMedSci, Former Chairman of the UK’s Medicines and Healthcare products...
Cambium Networks Corporation Announces First Quarter 2021 Reporting Date
ROLLING MEADOWS, Ill., April 20, 2021 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium Networks”) (NASDAQ: CMBM), a leading provider of...
Cyclerion Therapeutics to Host Pipeline Update Webinar
Company to discuss clinical updates for CY6463, including Phase 2a studies in ADv and MELAS, and plans to initiate Phase...
ProQR Announces Annual Meeting of Shareholders
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company...
SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics
SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics Adds unique gene-independent approach to treat the later stages...
Acarix publishes the annual report for 2020
Press releaseMalmö, Sweden, April 20, 2021 Acarix publishes the annual report for 2020 Today, Tuesday April 20, Acarix is...
Leading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions in Open Label Study
CARLSBAD, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (“LBS” or "the Company"), a privately held company that...
Silo Wellness Appoints Phytomedicine Business Leader as Board Member
TORONTO, April 20, 2021 (GLOBE NEWSWIRE) -- Silo Wellness Inc. (CSE: SILO) (FRA:3K70), a wellness company in the psychedelics and...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
Company Announcement Net sales of DARZALEX® in the first quarter of 2021 totaled USD 1,365 millionGenmab receives royalties on worldwide...
GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex
– Tuberous sclerosis complex (TSC) represents a third indication for GW’s cannabidiol in Europe – – TSC causes epilepsy in...
Embark Delta Inc. Completes New Product Shipment to Province of British Columbia
Toronto, Ontario--(Newsfile Corp. - April 20, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine
Intuitive, optical-based technology system now available around the world LONDON--(BUSINESS WIRE)--#510k--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company,...
SR Health Expands Technology Leadership Team to Support Patient-Provider Engagement
Chris Marsh and Vinitha Ramnathan bring nearly 40 years of combined healthcare experience to support the communication needs of healthcare...
Intersect ENT to Report First Quarter 2021 Financial Results
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to...
XPhyto adds Top-Level Executive Talent to its Global Operations
VANCOUVER, BC / ACCESSWIRE / April 20, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to...
Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse
J.POD(R) 2 EU BIOMANUFACTURING WILL PLAY A KEY ROLE IN ADDRESSING THE NEED FOR THERAPEUTIC ANTIBODIES, INCLUDING THOSE RELATED TO...
Implanet Reports Q1 2021 Revenue of €1.7 Million, Driven by the Dramatic Growth of Its Spine Activity
Global revenue growth: +7%, driven by +13% increase in direct sales Growth in JAZZ® Spine activity: +41% A webinar will...